Recursion Pharmaceuticals (RXRX) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.45
-0.42
-0.4
-0.37

Details

Expected EPS
-0.423333
Actual EPS
-0.39
Surprise EPS
0.03
Surprise Percent
+7.87%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.39 per share for Q2 2024.

0 Comments

Share your thoughts